Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder
Authors:
Open Access
- 1 May 1998
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 3 (3) , 270-273
Abstract
Obsessive compulsive disorder (OCD) is characterized by recurrent and intrusive thoughts that are distressing (obsessions) and/or repetitive behaviors or mental acts that the person feels driven to perform (compulsions). OCD has a partly genetic basis. For treatment of OCD, potent serotonin reuptake inhibitor (SRI) drugs (clomipramine (Anafranil), fluvoxamine (Luvox), fluoxetine (Prozac), sertraline (Zoloft), and paroxetine (Paxil)), which act on the serotonin transporter protein, are uniquely efficacious. A polymorphism in the promoter region of the gene (SLC6A4) encoding this protein,1 was recently reported to affect protein expression and to be associated with measures of anxiety and depression2 and with autism (using a family-controlled transmission disequilibrium test (TDT) design).3 SLC6A4 therefore has strong a priori support for potentially influencing risk for OCD: the protein it encodes is a medication target; a polymorphism in the gene affects function; and that polymorphism has been shown to be associated with behavioral phenotypes. We used the TDT with a set of 34 European-American family trios, 30 unrelated and four drawn from an extended pedigree, to test for linkage disequilibrium between OCD and alleles at the SLC6A4 promoter polymorphic locus. Of 35 heterozygous parents, 24 transmitted the ‘l’ SLC6A4 allele and 11 transmitted the ‘s’ allele (χ2TDT = 4.83; P2TDT = 3.77; P<0.052). these data provide preliminary support for association and linkage disequilibrium between the slc6a4 ‘l’ allele and ocd.Keywords
This publication has 15 references indexed in Scilit:
- Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjectsHuman Genetics, 1997
- Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorderProceedings of the National Academy of Sciences, 1997
- A Double-blind, Placebo-Controlled Study of Fluvoxamine in Adults With Autistic DisorderArchives of General Psychiatry, 1996
- Intact coding region of the serotonin transporter gene in obsessive-compulsive disorderAmerican Journal of Medical Genetics, 1996
- Allelic Variation of Human Serotonin Transporter Gene ExpressionJournal of Neurochemistry, 1996
- Double-blind Parallel Comparison of Three Dosages of Sertraline and Placebo in Outpatients With Obsessive-compulsive DisorderArchives of General Psychiatry, 1995
- A Multicenter Investigation of Fixed-Dose Fluoxetine in the Treatment of Obsessive-compulsive DisorderArchives of General Psychiatry, 1994
- Organization of the human serotonin transporter geneJournal of Neural Transmission, 1994
- The Epidemiology of Obsessive-Compulsive Disorder in Five US CommunitiesArchives of General Psychiatry, 1988
- The description of personality: basic traits resolved into clusters.The Journal of Abnormal and Social Psychology, 1943